3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Advanced Solid Tumor
3
Neoplasm Metastasis
2
Melanoma
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumour
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
Temozolomide
24
Radiotherapy
10
Magnetic Resonance Spectroscopy
9
Radiation
8
Specimen Handling
6
Lomustine
5
Bevacizumab
4
Nivolumab
3
Aminolevulinic Acid
3
veliparib
2
trametinib
2
olaparib
2
lutetium Lu 177 dotatate
2
dabrafenib
2
cemiplimab
2
azeliragon
2
Surgical Procedures, Operative
2
Receptors, Interleukin-8B
2
Photons
2
Palliative Care
2
Ipilimumab
2
D2C7-(scdsFv)-PE38KDEL
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
vocimagene amiretrorepvec
1
varlilumab
1
ulixertinib
1
tinostamustine
1
temsirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
tislelizumab
×
30 days
×
Clear all
No trials found.